mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |